We observed that treating tumor cells with anti-PD-L1 rFab’ for 72 h the invasiveness of both FaDu and SCC-011 cells was reduced to 46% and 66%, respectively, compared to control (Fig. 9B). Here, CD274 is linked to neoplasm.